Revvity Inc (RVTY)
112.42
+1.31
(+1.18%)
USD |
NYSE |
Nov 22, 14:28
Revvity Enterprise Value: 15.48B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 15.48B |
| November 20, 2024 | 15.51B |
| November 19, 2024 | 15.33B |
| November 18, 2024 | 15.28B |
| November 15, 2024 | 15.29B |
| November 14, 2024 | 16.08B |
| November 13, 2024 | 16.53B |
| November 12, 2024 | 16.60B |
| November 11, 2024 | 16.64B |
| November 08, 2024 | 16.86B |
| November 07, 2024 | 17.05B |
| November 06, 2024 | 17.15B |
| November 05, 2024 | 17.29B |
| November 04, 2024 | 17.15B |
| November 01, 2024 | 16.69B |
| October 31, 2024 | 16.44B |
| October 30, 2024 | 16.61B |
| October 29, 2024 | 16.33B |
| October 28, 2024 | 16.30B |
| October 25, 2024 | 16.16B |
| October 24, 2024 | 16.14B |
| October 23, 2024 | 16.42B |
| October 22, 2024 | 16.46B |
| October 21, 2024 | 16.52B |
| October 18, 2024 | 16.57B |
| Date | Value |
|---|---|
| October 17, 2024 | 16.49B |
| October 16, 2024 | 16.63B |
| October 15, 2024 | 17.14B |
| October 14, 2024 | 16.96B |
| October 11, 2024 | 16.79B |
| October 10, 2024 | 16.64B |
| October 09, 2024 | 16.79B |
| October 08, 2024 | 16.86B |
| October 07, 2024 | 16.92B |
| October 04, 2024 | 17.09B |
| October 03, 2024 | 17.11B |
| October 02, 2024 | 17.23B |
| October 01, 2024 | 17.15B |
| September 30, 2024 | 17.55B |
| September 27, 2024 | 17.47B |
| September 26, 2024 | 17.50B |
| September 25, 2024 | 16.98B |
| September 24, 2024 | 17.33B |
| September 23, 2024 | 16.98B |
| September 20, 2024 | 17.08B |
| September 19, 2024 | 17.52B |
| September 18, 2024 | 17.29B |
| September 17, 2024 | 17.05B |
| September 16, 2024 | 17.07B |
| September 13, 2024 | 16.97B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.307B
Minimum
Mar 16 2020
29.80B
Maximum
Dec 30 2021
18.13B
Average
16.86B
Median
Nov 08 2024
Enterprise Value Benchmarks
| Bionano Genomics Inc | 14.35M |
| Bruker Corp | 10.71B |
| Azenta Inc | 1.613B |
| Harvard Bioscience Inc | 127.50M |
| Akoya Biosciences Inc | 145.08M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 94.37M |
| Revenue (Quarterly) | 684.05M |
| Total Expenses (Quarterly) | 587.85M |
| EPS Diluted (Quarterly) | 0.77 |
| Gross Profit Margin (Quarterly) | 56.26% |
| Profit Margin (Quarterly) | 13.80% |
| Earnings Yield | 1.84% |
| Operating Earnings Yield | 2.19% |
| Normalized Earnings Yield | 1.948 |